The Global Fund maintains flexibilities to ensure the continued flow of quality-assured health products and support countries in their response to COVID-19.
Our operational guidance for Principal Recipients relates to requirements for procuring eligible COVID-19 diagnostic products and managing exceptions on quality assurance testing and sampling. Additionally, we regularly update our list of COVID-19 diagnostic products eligible for procurement with Global Fund financing, in line with our Interim Quality Assurance Requirements.
Information related to the quality assurance of health products related to the three diseases is on our Quality Assurance pages.